Mankind Pharma Limited (NSE:MANKIND)
2,107.60
-39.40 (-1.84%)
At close: Jan 23, 2026
-16.25% (1Y)
| Market Cap | 886.29B |
| Revenue (ttm) | 135.46B |
| Net Income (ttm) | 17.51B |
| Shares Out | 412.81M |
| EPS (ttm) | 42.63 |
| PE Ratio | 50.43 |
| Forward PE | 38.74 |
| Dividend | 2.00 (0.09%) |
| Ex-Dividend Date | Aug 8, 2025 |
| Volume | 406,709 |
| Average Volume | 329,937 |
| Open | 2,150.90 |
| Previous Close | 2,147.00 |
| Day's Range | 2,098.00 - 2,155.00 |
| 52-Week Range | 2,081.90 - 2,716.50 |
| Beta | 0.27 |
| RSI | 41.45 |
| Earnings Date | Feb 3, 2026 |